First results of an eye lens dosimetry survey in an interventional cardiology department

2015 ◽  
Vol 35 (2) ◽  
pp. 467-472 ◽  
Author(s):  
P Ferrari ◽  
F Mariotti ◽  
L Campani ◽  
D M Castelluccio ◽  
L Pierotti ◽  
...  
2016 ◽  
Vol 57 (4) ◽  
pp. 431-437 ◽  
Author(s):  
Joanna Domienik ◽  
Szymon Gryglak ◽  
Joanna Jurewicz

Abstract Preliminary results of the Polish epidemiology study on eye lens opacities among interventional cardiologists (ICs), based on the methodology proposed by ELDO (epidemiological studies of radio-induced cataracts in interventional cardiologists and radiologists: methodology implementation), are presented. The aim of the study is to test the hypothesis concerning the excess risk of cataract in the group of ICs. The first results concern the study population characteristics, including the most important confounding factors for cataract, as well as a detailed description of the work practices in interventional cardiology needed in order to reconstruct the cumulative eye lens dose. The data from 69 ICs and 23 controls collected based on the general medical questionnaire and the occupational questionnaire (for ICs only) were analyzed. The mean age of ICs and of the control group was 41 and 44, respectively, while the mean duration of work for exposed physicians was 9 years. The analysis of the data from the occupational questionnaire concerning the procedures performed, the use of various access routes, as well as radiation protection tools (eye lens glasses, ceiling suspended transparent shield, etc.) are also presented. On the basis of this information and additional assumptions about the doses per procedure (as well as reduction factors for various types of radiation measures), the cumulative doses to the eye lens of ICs were evaluated. They ranged up to 1.55 Sv and 0.4 Sv for left and right eye, respectively; however, the dose to only 3% of ICs exceeded the new threshold for development of eye lens opacities (0.5 Gy) proposed by the ICRP.


2009 ◽  
Vol 138 (2) ◽  
pp. 180-186 ◽  
Author(s):  
Z. Brnic ◽  
T. Krpan ◽  
D. Faj ◽  
D. Kubelka ◽  
J. P. Ramac ◽  
...  

2020 ◽  
Vol 135 ◽  
pp. 106385
Author(s):  
Marija Surić Mihić ◽  
Luka Pavelić ◽  
Maja Vojnić Kortmiš ◽  
Jerko Šiško ◽  
Nadica Maltar-Strmečki ◽  
...  

2010 ◽  
Vol 144 (1-4) ◽  
pp. 442-447 ◽  
Author(s):  
J. Domienik ◽  
M. Brodecki ◽  
E. Carinou ◽  
L. Donadille ◽  
J. Jankowski ◽  
...  

2016 ◽  
Vol 36 (2) ◽  
pp. 309-318 ◽  
Author(s):  
J Domienik ◽  
A Bissinger ◽  
W Grabowicz ◽  
Ł Jankowski ◽  
R Kręcki ◽  
...  

2016 ◽  
pp. 61-68
Author(s):  
Anh Tien Hoang ◽  
Thị Thanh Truc Tran ◽  
Thanh Nhan Vo

Background: Serum levels of ST2 are associated with prognosis in nonischemic heart failure, but the predictive value of ST2 in patients with ST elevation myocardial infarction is unknown. Methods: The study included 38 STEMI patients at Interventional Cardiology department of Cho ray hospital. Correlation analysis was used to identify the relationship between the cardiac outcomes within 30 days from the onset of chest pain and sST2 value. Results: ST2 levels were measured in serum from 38 patients with STEMI. Baseline levels of ST2 were significantly higher in those patients who died (<35 ng/ml versus >35 ng/mL, P=0,01) or developed new congestive heart failure (< 35 ng/ml versus > 35 ng/mL, P=0.002) by 30 days. In an analysis of outcomes at 30 days by ST2 quartiles, both death (P=0.01) and the combined death/heart failure end point (p=0.001) showed a significant graded association with levels of ST2. Furthermore, when sST2 > 35 ng/ml and BNP > 500 pg/ml showed a tightly relationship with cardiac outcomes within 30 days (P<0,0001). Conclusions: Serum levels of the interleukin-1 receptor family member ST2 predict mortality and heart failure in patients with STEMI. These data suggest that ST2 and BNP are the useful biomarker in short-term prognosis of cardiac events in STEMI. Key words: sST2, BNP, STEMI, cardiac outcomes


Author(s):  
Zoi Thrapsanioti ◽  
Panagiotis Askounis ◽  
Ioannis Datseris ◽  
Ramza Anastasia Diamanti ◽  
Miltiadis Papathanasiou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document